{"id":49290,"date":"2022-10-06T18:01:56","date_gmt":"2022-10-06T16:01:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/"},"modified":"2022-10-06T18:01:56","modified_gmt":"2022-10-06T16:01:56","slug":"life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/","title":{"rendered":"Life Sciences BC Announces Companies and Mentors of Third Annual Investor Readiness Program"},"content":{"rendered":"<div>\n<p>VANCOUVER, British Columbia&#8211;(BUSINESS WIRE)&#8211;Life Sciences BC today announced the companies and mentors participating in its 2023 Investor Readiness Program (IRP). Through an intensive six-month program, 10 early-stage small and mid-size enterprises (SMEs) in British Columbia\u2019s life sciences sector are paired with 10 entrepreneurs-in-residence (EIRs) to support the SMEs to become investor-ready. The industry expertise and acumen of the mentors provides the up-and-coming companies invaluable insight and support, which will culminate in a final pitch session with pre-qualified investors at the end of the program.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221006005144\/en\/1593258\/5\/LifeSciencesBC_ID_F.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221006005144\/en\/1593258\/21\/LifeSciencesBC_ID_F.jpg\"><\/a><\/p>\n<p>\nCompanies and mentors are paired according to skillset, experience and interests. The SMEs and EIRs selected for the 2023 IRP are:\n<\/p>\n<p>\n<b>SMEs<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fazorbiotek.ca%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=Azor+Biotek&amp;index=1&amp;md5=7d21f7991c4bc6c0aca76997aae0f57b\" rel=\"nofollow noopener\" shape=\"rect\">Azor Biotek<\/a>\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.clariventmedical.com%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=Clarivent+Medical&amp;index=2&amp;md5=a940f4edf659793a1b2b1d192c70eed6\" rel=\"nofollow noopener\" shape=\"rect\">Clarivent Medical<\/a>\n<\/li>\n<li>\nCloak Scientific Inc.\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fderm-biomepharmaceuticals.com%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=Derm-Biome+Pharmaceuticals+Inc&amp;index=3&amp;md5=3bea02e5b26e53cfc565b3714abd9d56\" rel=\"nofollow noopener\" shape=\"rect\">Derm-Biome Pharmaceuticals Inc<\/a>.\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fezpttech.com%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=ezPT+Technologies+Ltd&amp;index=4&amp;md5=2a01464348e1cb4617d9cc1728a65d63\" rel=\"nofollow noopener\" shape=\"rect\">ezPT Technologies Ltd<\/a>\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.yourhealthqb.com%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=HealthQb+Technologies%2C+Inc.&amp;index=5&amp;md5=7938ab52eeebf41256f42505e0478a2f\" rel=\"nofollow noopener\" shape=\"rect\">HealthQb Technologies, Inc.<\/a>\n<\/li>\n<li>\nIndividual Health Technology <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.makahealth.com%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=%28Maka+Health&amp;index=6&amp;md5=1d60b4c86c27d32d95c06b7193389ab2\" rel=\"nofollow noopener\" shape=\"rect\">(Maka Health<\/a>)\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fintegratedntx.com%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=Integrated+Nanotherapeutics+Inc.&amp;index=7&amp;md5=94ea2bda914d42bdf02e2def8ffbae66\" rel=\"nofollow noopener\" shape=\"rect\">Integrated Nanotherapeutics Inc.<\/a>\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fiuvoxtech.com%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=IUVOX&amp;index=8&amp;md5=251d1efa10719785ddd10972a805257b\" rel=\"nofollow noopener\" shape=\"rect\">IUVOX<\/a>\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fmesintel.com%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=Mesintel+Therapeutics+Inc.&amp;index=9&amp;md5=31237fce3617a537f9d68b7e4333ea09\" rel=\"nofollow noopener\" shape=\"rect\">Mesintel Therapeutics Inc.<\/a>\n<\/li>\n<\/ul>\n<p>\n<b>EIR Mentors<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nNancy Harrison, Venture Partner, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Famplitudevc.com%2Fen&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=Amplitude+Ventures&amp;index=10&amp;md5=159f222c57b4c71d22ee6a221e38a28d\" rel=\"nofollow noopener\" shape=\"rect\">Amplitude Ventures<\/a>\n<\/li>\n<li>\nLivleen Veslemes, Consulting Executive, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.veslemes.com%2F%23%3A~%3Atext%3DVeslemes%2520Growth%2520Partners-%2CAbout%2Cin%2520a%2520fiscally%2520forward%2520way.&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=Veslemes+Growth+Partners&amp;index=11&amp;md5=a6c89d7c259182a768cfb88f5e0b06b0\" rel=\"nofollow noopener\" shape=\"rect\">Veslemes Growth Partners<\/a>\n<\/li>\n<li>\nTom Frohlich, COO, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.chinooktx.com%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=Chinook+Therapeutics&amp;index=12&amp;md5=05357fc7fd339747ad5417697ea2840e\" rel=\"nofollow noopener\" shape=\"rect\">Chinook Therapeutics<\/a>\n<\/li>\n<li>\nNorma Sebestyen, Consultant, Life Sciences Executive\n<\/li>\n<li>\nDavid Helliwell, Co-founder and Executive Board Chair, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.thrive.health%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=Thrive+Health&amp;index=13&amp;md5=ce4ea8618ff14e34882e96b3ac5a73d5\" rel=\"nofollow noopener\" shape=\"rect\">Thrive Health<\/a>\n<\/li>\n<li>\nBrenda Irwin, Managing Partner, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.relentlesspursuitpartners.com%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=Relentless+Venture+Fund&amp;index=14&amp;md5=7238f4c89bd9a365201c41e6572f79eb\" rel=\"nofollow noopener\" shape=\"rect\">Relentless Venture Fund<\/a>\n<\/li>\n<li>\nNatalie Dakers, Corporate Director and Entrepreneur, Life Sciences Executive\n<\/li>\n<li>\nJason Robertson, Co-founder and Vice President, Investments, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.nimbusinc.vc%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=Nimbus+Synergies+Inc.&amp;index=15&amp;md5=a3db8e7266846941c8179dca78cd5924\" rel=\"nofollow noopener\" shape=\"rect\">Nimbus Synergies Inc.<\/a>\n<\/li>\n<li>\nMalcolm Kendall, Co-founder and CEO, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fmicrobiomeinsights.com%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=Microbiome+Insights+Inc.&amp;index=16&amp;md5=ccdcc311b68dc44b8999e11cf84db9ad\" rel=\"nofollow noopener\" shape=\"rect\">Microbiome Insights Inc.<\/a>\n<\/li>\n<\/ul>\n<p>\nThe program, which runs from October to March, is designed around individual coaching and is complemented by educational sessions, goal setting, peer-to-peer feedback, conference opportunities and group meetings. Applications for next year\u2019s program will open in spring 2023.\n<\/p>\n<p>\n<i>*This program is supported in part by funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).<\/i>\n<\/p>\n<p>\n<b>Quotes:<\/b>\n<\/p>\n<p>\n\u201cWe are thrilled to welcome the participants for our third annual Investor Readiness Program, which is designed to ensure our newest companies are poised to attract investment via education and mentoring. The pace of BC\u2019s dynamic life sciences ecosystem continues to grow at an unprecedented rate, and we are grateful to the NRC IRAP for their support of this important program, and to our entrepreneurs-in-residence for their commitment and leadership. We are looking forward to following our SMEs on this exciting investor journey.\u201d\n<\/p>\n<p>\n<b>Wendy Hurlburt, President and CEO, <\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Flifesciencesbc.ca%2Fstaff-category%2Fmanagement%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=Life+Sciences+BC&amp;index=17&amp;md5=da6226f7160aea6336569c2b7a1b0234\" rel=\"nofollow noopener\" shape=\"rect\"><b>Life Sciences BC<\/b><\/a>\n<\/p>\n<p>\n\u201cThis is a great program where you can network with people, learn new knowledge and practice your presentation skills. Highly recommend!\u201d\n<\/p>\n<p>\n<b>Jack Jin, COO, Primary Peptides, IRP Graduate 2021<\/b>\n<\/p>\n<p>\n\u201cThought leadership and feedback sessions from industry experts in the IRP paired with mentorship from executive-in-residence Tom Frohlich, pushed Eyam to think more strategically for growth and to advance preclinical work into clinical trials.\u201d\n<\/p>\n<p>\n<b>Dr. Pamela Lincez, Director of Operations, Eyam, IRP Graduate 2022<\/b>\n<\/p>\n<p>\n\u201cI really like this program. Very focused, efficient and effective. I have found the quality of participants high and that the EIRs added lots of value.\u201d\n<\/p>\n<p>\n<b>Malcolm Kendall, IRP EIR 2021, 2022, and 2023<\/b>\n<\/p>\n<p>\n<i>For more information about the Investor Readiness Program, please contact William Burrows, Director, Business Operations and Programs: <a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x77;&#98;&#x75;&#114;&#x72;&#111;&#x77;&#115;&#x40;&#108;&#x69;&#102;&#x65;&#115;&#x63;&#105;&#x65;&#110;&#x63;&#101;&#x73;&#98;&#x63;&#46;&#x63;&#97;\" rel=\"nofollow noopener\" shape=\"rect\">wb&#117;&#114;&#x72;&#x6f;&#x77;&#x73;&#64;l&#105;&#102;&#x65;&#x73;&#x63;&#x69;en&#99;&#101;&#115;&#x62;&#x63;&#x2e;&#x63;a<\/a> 604 669 9099 ext: 101<\/i>\n<\/p>\n<p>\n<b>About Life Sciences BC<\/b>\n<\/p>\n<p>\nLife Sciences BC is a not-for-profit, non-government association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, and promotion of our world-class science and industry.\n<\/p>\n<p>\nLife sciences sectors, from biopharmaceuticals and medical technology to digital health and medical devices, are integrated into our organization and all that we do, ensuring that no life sciences sector is working in isolation \u2014 and that all sectors come together in a comprehensive, complementary and coordinated fashion.\n<\/p>\n<p>\nThroughout the year, Life Sciences BC undertakes numerous programs and projects in support of these sectors. These include public policy initiatives, facilitating linkages between global industry and our local organizations, raising the profile of our industry internationally and thus facilitating investment and global partnering opportunities, and helping nurture economic development in British Columbia through the life sciences industry.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nJohanna Mills<br \/>\n<br \/>Manager, Marketing &amp; Communications, Life Sciences BC<br \/>\n<br \/>Email: <a target=\"_blank\" href=\"mailto:j&#109;&#105;&#108;&#108;&#115;&#64;&#108;&#105;&#102;&#101;&#x73;&#x63;&#x69;&#x65;&#x6e;&#x63;&#x65;&#x73;&#x62;&#x63;&#x2e;&#x63;&#x61;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6a;&#x6d;&#x69;&#x6c;&#108;&#115;&#64;li&#x66;&#x65;&#x73;&#x63;&#x69;&#101;&#110;&#99;es&#x62;&#x63;&#x2e;&#x63;&#x61;<\/a><br \/>Mobile: (604) 358-9591<br \/>\n<br \/>Web: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.lifesciencesbc.ca%2F&amp;esheet=52938002&amp;newsitemid=20221006005144&amp;lan=en-US&amp;anchor=www.lifesciencesbc.ca&amp;index=18&amp;md5=2473618cf2eb7d0d1d48fe3ecbba6a58\" rel=\"nofollow noopener\" shape=\"rect\">www.lifesciencesbc.ca<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, British Columbia&#8211;(BUSINESS WIRE)&#8211;Life Sciences BC today announced the companies and mentors participating in its 2023 Investor Readiness Program (IRP). Through an intensive six-month program, 10 early-stage small and mid-size enterprises (SMEs) in British Columbia\u2019s life sciences sector are paired with 10 entrepreneurs-in-residence (EIRs) to support the SMEs to become investor-ready. The industry expertise and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49290","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Life Sciences BC Announces Companies and Mentors of Third Annual Investor Readiness Program - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Life Sciences BC Announces Companies and Mentors of Third Annual Investor Readiness Program - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia&#8211;(BUSINESS WIRE)&#8211;Life Sciences BC today announced the companies and mentors participating in its 2023 Investor Readiness Program (IRP). Through an intensive six-month program, 10 early-stage small and mid-size enterprises (SMEs) in British Columbia\u2019s life sciences sector are paired with 10 entrepreneurs-in-residence (EIRs) to support the SMEs to become investor-ready. The industry expertise and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-06T16:01:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221006005144\/en\/1593258\/21\/LifeSciencesBC_ID_F.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Life Sciences BC Announces Companies and Mentors of Third Annual Investor Readiness Program\",\"datePublished\":\"2022-10-06T16:01:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\\\/\"},\"wordCount\":653,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221006005144\\\/en\\\/1593258\\\/21\\\/LifeSciencesBC_ID_F.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\\\/\",\"name\":\"Life Sciences BC Announces Companies and Mentors of Third Annual Investor Readiness Program - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221006005144\\\/en\\\/1593258\\\/21\\\/LifeSciencesBC_ID_F.jpg\",\"datePublished\":\"2022-10-06T16:01:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221006005144\\\/en\\\/1593258\\\/21\\\/LifeSciencesBC_ID_F.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221006005144\\\/en\\\/1593258\\\/21\\\/LifeSciencesBC_ID_F.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Life Sciences BC Announces Companies and Mentors of Third Annual Investor Readiness Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Life Sciences BC Announces Companies and Mentors of Third Annual Investor Readiness Program - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/","og_locale":"en_US","og_type":"article","og_title":"Life Sciences BC Announces Companies and Mentors of Third Annual Investor Readiness Program - Pharma Trend","og_description":"VANCOUVER, British Columbia&#8211;(BUSINESS WIRE)&#8211;Life Sciences BC today announced the companies and mentors participating in its 2023 Investor Readiness Program (IRP). Through an intensive six-month program, 10 early-stage small and mid-size enterprises (SMEs) in British Columbia\u2019s life sciences sector are paired with 10 entrepreneurs-in-residence (EIRs) to support the SMEs to become investor-ready. The industry expertise and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-06T16:01:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221006005144\/en\/1593258\/21\/LifeSciencesBC_ID_F.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Life Sciences BC Announces Companies and Mentors of Third Annual Investor Readiness Program","datePublished":"2022-10-06T16:01:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/"},"wordCount":653,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221006005144\/en\/1593258\/21\/LifeSciencesBC_ID_F.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/","url":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/","name":"Life Sciences BC Announces Companies and Mentors of Third Annual Investor Readiness Program - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221006005144\/en\/1593258\/21\/LifeSciencesBC_ID_F.jpg","datePublished":"2022-10-06T16:01:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221006005144\/en\/1593258\/21\/LifeSciencesBC_ID_F.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221006005144\/en\/1593258\/21\/LifeSciencesBC_ID_F.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/life-sciences-bc-announces-companies-and-mentors-of-third-annual-investor-readiness-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Life Sciences BC Announces Companies and Mentors of Third Annual Investor Readiness Program"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49290"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49290\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49290"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}